Analytical similarity as the primary determinant of monoclonal antibody development: toward evidence-efficient regulatory frameworks
{{output}}
Monoclonal antibodies (mAbs) constitute the most rapidly expanding and therapeutically impactful class of biological medicines, driven by their exceptional target specificity, modular engineering capabilities, predictable pharmacokinetics facilitated by neonat... ...
